|
|
|
|
|
|
|
||
Activation and Desensitization of the Recombinant P2X1 Receptor at Nanomolar ATP Concentrations
Address correspondence to J. Rettinger, University Medical School, RWTH Aachen, Department of Molecular Pharmacology, Wendlingweg 2, D-52074 Aachen, Germany. Fax (49) 241 8082433; E-mail: jrett{at}web.de
Activation and desensitization kinetics of the rat P2X1 receptor at nanomolar ATP concentrations were studied in Xenopus oocytes using two-electrode voltage-clamp recording. The solution exchange system used allowed complete and reproducible solution exchange in <0.5 s. Sustained exposure to 1–100 nM ATP led to a profound desensitization of P2X1 receptors. At steady-state, desensitization could be described by the Hill equation with a K1/2 value of 3.2 ± 0.1 nM. Also, the ATP dependence of peak currents could be described by a Hill equation with an EC50 value of 0.7 µM. Accordingly, ATP dose-effect relationships of activation and desensitization practically do not overlap. Recovery from desensitization could be described by a monoexponential function with the time-constant
= 11.6 ±1.0 min. Current transients at 10–100 nM ATP, which elicited 0.1–8.5% of the maximum response, were compatible with a linear three-state model, C-O-D (closed-open-desensitized), with an ATP concentration-dependent activation rate and an ATP concentration-independent (constant) desensitization rate. In the range of 18–300 nM ATP, the total areas under the elicited current transients were equal, suggesting that P2X1 receptor desensitization occurs exclusively via the open conformation. Hence, our results are compatible with a model, according to which P2X1 receptor activation and desensitization follow the same reaction pathway, i.e., without significant C to D transition. We assume that the K1/2 of 3.2 nM for receptor desensitization reflects the nanomolar ATP affinity of the receptor found by others in agonist binding experiments. The high EC50 value of 0.7 µM for receptor activation is a consequence of fast desensitization combined with nonsteady-state conditions during recording of peak currents, which are the basis of the dose-response curve. Our results imply that nanomolar extracellular ATP concentrations can obscure P2X1 receptor responses by driving a significant fraction of the receptor pool into a long-lasting refractory closed state.
Key Words: P2X receptor • desensitization • activation
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Sim, H. E. Broomhead, and R. A. North Ectodomain Lysines and Suramin Block of P2X1 Receptors J. Biol. Chem., October 31, 2008; 283(44): 29841 - 29846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Karoly, A. Mike, P. Illes, and Z. Gerevich The Unusual State-Dependent Affinity of P2X3 Receptors Can Be Explained by an Allosteric Two-Open-State Model Mol. Pharmacol., January 1, 2008; 73(1): 224 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schaefer, T. Machida, M. J. Broekman, A. J. Marcus, and R. Levi Targeted Deletion of Ectonucleoside Triphosphate Diphosphohydrolase 1/CD39 Leads to Desensitization of Pre- and Postsynaptic Purinergic P2 Receptors J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1269 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Marquez-Klaka, J. Rettinger, Y. Bhargava, T. Eisele, and A. Nicke Identification of an Intersubunit Cross-Link between Substituted Cysteine Residues Located in the Putative ATP Binding Site of the P2X1 Receptor J. Neurosci., February 7, 2007; 27(6): 1456 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Duckwitz, R. Hausmann, A. Aschrafi, and G. Schmalzing P2X5 Subunit Assembly Requires Scaffolding by the Second Transmembrane Domain and a Conserved Aspartate J. Biol. Chem., December 22, 2006; 281(51): 39561 - 39572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sokolova, A. Skorinkin, I. Moiseev, A. Agrachev, A. Nistri, and R. Giniatullin Experimental and Modeling Studies of Desensitization of P2X3 Receptors Mol. Pharmacol., July 1, 2006; 70(1): 373 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Ford, M. Matchett, J. E. Krause, and W. Yu The P2X3 Antagonist P1, P5-Di[inosine-5'] Pentaphosphate Binds to the Desensitized State of the Receptor in Rat Dorsal Root Ganglion Neurons J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 405 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tolhurst, C. Vial, C. Leon, C. Gachet, R. J. Evans, and M. P. Mahaut-Smith Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling Blood, September 1, 2005; 106(5): 1644 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Pratt, T. S. Brink, P. Bergson, M. M. Voigt, and S. P. Cook Use-Dependent Inhibition of P2X3 Receptors by Nanomolar Agonist J. Neurosci., August 10, 2005; 25(32): 7359 - 7365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Roberts and R. J. Evans ATP Binding at Human P2X1 Receptors: CONTRIBUTION OF AROMATIC AND BASIC AMINO ACIDS REVEALED USING MUTAGENESIS AND PARTIAL AGONISTS J. Biol. Chem., March 5, 2004; 279(10): 9043 - 9055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rettinger and G. Schmalzing Desensitization Masks Nanomolar Potency of ATP for the P2X1 Receptor J. Biol. Chem., February 20, 2004; 279(8): 6426 - 6433. [Abstract] [Full Text] [PDF]
|
|
|
|
